期刊文献+

二十二碳六烯酸抑制慢性阻塞性肺疾病患者中性粒细胞核因子-κB p65的表达 被引量:2

DHA suppresses NF-κB p65 expression in neutrophils in patients with chronic obstructive pulmonary disease
暂未订购
导出
摘要 目的:探讨二十二碳六烯酸(DHA)在慢性阻塞性肺疾病(COPD)中的抗炎机制。方法选取2011年12月至2012年12月在上海市徐汇区中心医院门诊就诊的患者40例,其中COPD稳定期患者20例为A组,COPD发作期患者20例为B组,分离外周静脉血中性粒细胞体外培养,用不同浓度的DHA(10,50和100μmol/L)处理0~72h(0,24,48和72h),收取培养液上清测定炎症因子白细胞介素(IL)-6,IL-8和肿瘤坏死因子α(TNF-α)水平,收取细胞蛋白做Western印迹法检测核因子κB(NF-κB)p65的表达。结果 DHA作用前B组炎症因子水平显著高于A组。DHA作用后,两组炎症因子水平都下降,并呈现浓度和时间依赖效应,B组下降趋势大于A组,高浓度DHA作用72h后,A组和B组炎症因子水平趋于一致。NF-κB p65的表达水平随DHA浓度和时间变化呈现下降趋势(P<0.05)。结论 DHA可能通过抑制中性粒细胞的NF-κB p65蛋白的表达,显著性地降低了中性粒细胞分泌炎症因子IL-6、IL-8、TNF-α的水平,为DHA用于临床治疗COPD提供了理论依据。 Objective To investigate the anti-inflammatory effect and mechanism of docosahexaenoic acid (DHA) in patients with chronic obstructive pulmonary disease (COPD). Methods A total of 40 COPD outpatients in our department from December 2011 to December 2012 were recruited in this study. Twenty cases of them in stable period were assigned as group A, and the left 20 cases in exacerbation period were assigned into group B. Their peripheral blood neutrophils were isolated and cultivated. Then the cells were treated with DHA at different concentrations (10, 50 and 100μmol/L) for 0, 24, 48 and 72h, respectively. The levels of the inflammatory cytokines IL-6, IL-8, and TNF-αin culture supernatants were measured. The expression level of NF-κB p65 protein was detected with Western blotting. Results Before DHA treatment, the levels of inflammatory factors were significantly higher in group B than in group A. After DHA treatment, the levels dropped directly in a concentration- and time-dependent manner in both groups, but the downtrend was stronger in group B than in group A. After treated with high dosed DHA for 72h, the inflammatory cytokines levels in group A were not significantly different with those in group B. NF-κB p65 protein expression was decreased in a dose-and time-dependent manner (P〈0.05). Conclusions DHA significantly reduces the levels of inflammatory cytokines IL-6, IL-8, and TNF-α through inhibiting NF-κB p65 protein expression in neutrophils, providing the theoretical basis for DHA in clinical treatment of COPD.
出处 《中华老年多器官疾病杂志》 2014年第1期54-58,共5页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 二十二碳六烯酸 肺疾病 慢性阻塞性 转录因子-RelA docosahexaenoic acid pulmonary disease, chronic obstructive transcription factor RelA
  • 相关文献

参考文献1

二级参考文献21

  • 1Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782-787.
  • 2Covert MW, Leung TH, Gaston JE, Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 2005; 309: 1854-1857.
  • 3Palsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004; 113: 153-162.
  • 4Qin H, Wilson CA, Lee S J, Zhao X, Benveniste EN. LPS induces CD40 gene expression through the activation of NF- kappaB and STAT-1 alpha in macrophages and microglia. Blood 2005; 106: 3114-3122.
  • 5Rahman R, Grundy R. Histone deacetylase inhibition as an anticancer telomerase-targeting strategy. Int J Cancer 2011; 129: 2765-2774.
  • 6Choi JH, Oh SW, Kang MS, Kwon H J, Oh GT, Kim DY. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 2005; 35: 89-96.
  • 7Camelo S, Iglesias AH, Hwang D, Due B, Ryu H, Smith K, Gray SG, Imitola J, Duran G, Assaf B, Langley B, Khoury S J, Stephanopoulos G, De Girolami U, Ratan RR, Ferrante RJ, Dangond F. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol 2005; 164: 10-21.
  • 8Chung YL, lee M Y, Wang A J, Yao L F, A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol Ther 2003; 8: 707-717.
  • 9Roger T, Lugrin J, Le Roy D, Goy G, Mombelli M, Koessler T, Ding XC, Chanson AL, Reymond MK, Miconnet Ⅰ, Schrenzel J, Francois P, Calandra T. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 2011; 117:1205-1217.
  • 10Suuronen T, Huuskonen J, Pihlaja R, Kyrylenko S, Salminen A. Regulation of microglial inflammatory response by histone deacetylase inhibitors. J Neurochem 2003; 87:407-416.

共引文献4

同被引文献15

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部